ABSTRACT
The ethanol, aqueous/water and
ethyl acetate extracts of the leaves of Acalypha wilkesiana Musaica were
subjected to phytochemical and antibacterial studies. The phytochemical studies
showed the presence of alkaloid, saponin, tannin, phenol, flavonoid and
hydrogen cyanide (HCN) in varying concentrations from the different extracts.
The recorded concentrations were as follows; Aqueous extract (alkaloid = 0.97 ±
0.01, saponin 0.71 ± 0.02, tannin = 0.25 ± 0.01, phenol = 0.18 ± 0.01, flavonoid
= 0.22 ± 0.01, HCN 3.74 ± 0.33), Ethanol extract (alkaloid = 1.83 ± 0.01,
saponin = 0.41 ± 0.02, tannin = 0.87 ± 0.01, phenol 0.30 ± 0.02, flavonoid =
0.27 + 0.01, HCN = 1.11 ± 0.02) and Ethyl acetate extract (alkaloid = 0.99 ±
0.02, saponin = 0.19 ± 0.02, tannin = 0.11 ± 0.01, phenol 0.24 ± 0.01,
flavonoid = 0.25 ± 0.01, HCN = 0.00 + 0.00). The antibacterial activity of the
leaves of A. wilkesiana Musaica ethanol, aqueous and ethyl acetate extracts and
its fine derivative fractions were tested on Methicillin resistant
Staphylococcus aureus strains from clinical sources using the Mueller Hinton
Agar (MHA) and the zone of inhibition recorded. The mean zone of inhibition
recorded was; aqueous extract (16.72 mm), ethanol extract (14.46 mm) and ethyl
acetate extract (13.06 mm). Results showed that the extracts had inhibitory
action on the MRSA and the performance of the extracts against the MRSA on
average was close to that of the commercial antibiotic, Vancomycin (18.28 mm).
The aqueous extract was more potent than the ethanol and the ethyl acetate
extracts having 9 1.47% while, the other two had 79.19% and 7 1.52%
respectively. The MIC of the different extracts against the test organisms was
also determined. The MIC recorded for the aqueous and ethanol extract was 75
mg/mL having an inhibition diameter of 2.3 mm and 3.0mm respectively and MBC
was 100 mg/mL. For ethyl acetate, the MIC was 100 mg/mL with inhibition
diameter of 1.3 mm and MBC was recorded at 125 mg/mL. These results show that
the aqueous and ethanol extracts of this plant are more effective than the
ethyl acetate extract and is also indicative that the plant extracts could be
put to effective pharmacological applications.
EKEKE, O (2021). Study On The Antimicrobial Activities In Acalypha Wilkesiana Extracts Against Methicillin Resistant Staphylococcus Aureus Isolates From Clinical Samples. Mouau.afribary.org: Retrieved Nov 16, 2024, from https://repository.mouau.edu.ng/work/view/study-on-the-antimicrobial-activities-in-acalypha-wilkesiana-extracts-against-methicillin-resistant-staphylococcus-aureus-isolates-from-clinical-samples-7-2
OGECHI, EKEKE. "Study On The Antimicrobial Activities In Acalypha Wilkesiana Extracts Against Methicillin Resistant Staphylococcus Aureus Isolates From Clinical Samples" Mouau.afribary.org. Mouau.afribary.org, 28 Jul. 2021, https://repository.mouau.edu.ng/work/view/study-on-the-antimicrobial-activities-in-acalypha-wilkesiana-extracts-against-methicillin-resistant-staphylococcus-aureus-isolates-from-clinical-samples-7-2. Accessed 16 Nov. 2024.
OGECHI, EKEKE. "Study On The Antimicrobial Activities In Acalypha Wilkesiana Extracts Against Methicillin Resistant Staphylococcus Aureus Isolates From Clinical Samples". Mouau.afribary.org, Mouau.afribary.org, 28 Jul. 2021. Web. 16 Nov. 2024. < https://repository.mouau.edu.ng/work/view/study-on-the-antimicrobial-activities-in-acalypha-wilkesiana-extracts-against-methicillin-resistant-staphylococcus-aureus-isolates-from-clinical-samples-7-2 >.
OGECHI, EKEKE. "Study On The Antimicrobial Activities In Acalypha Wilkesiana Extracts Against Methicillin Resistant Staphylococcus Aureus Isolates From Clinical Samples" Mouau.afribary.org (2021). Accessed 16 Nov. 2024. https://repository.mouau.edu.ng/work/view/study-on-the-antimicrobial-activities-in-acalypha-wilkesiana-extracts-against-methicillin-resistant-staphylococcus-aureus-isolates-from-clinical-samples-7-2